|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1997-8-21
|
|
pubmed:abstractText |
Erythromycin has been shown to be a powerful prokinetic of the gastrointestinal tract. Little is known about its value to improve motility and transit in gastrectomized patients.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0007-1323
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
84
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1017-21
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9240156-Administration, Oral,
pubmed-meshheading:9240156-Adult,
pubmed-meshheading:9240156-Aged,
pubmed-meshheading:9240156-Erythromycin,
pubmed-meshheading:9240156-Female,
pubmed-meshheading:9240156-Gastrectomy,
pubmed-meshheading:9240156-Gastrointestinal Agents,
pubmed-meshheading:9240156-Gastrointestinal Motility,
pubmed-meshheading:9240156-Gastrointestinal Transit,
pubmed-meshheading:9240156-Humans,
pubmed-meshheading:9240156-Male,
pubmed-meshheading:9240156-Manometry,
pubmed-meshheading:9240156-Middle Aged,
pubmed-meshheading:9240156-Postoperative Period,
pubmed-meshheading:9240156-Stomach Neoplasms
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Oral erythromycin improves gastrointestinal motility and transit after subtotal but not total gastrectomy for cancer.
|
|
pubmed:affiliation |
Istituto di Clinica Chirurgica, Università degli Studi di Bari, Italy.
|
|
pubmed:publicationType |
Journal Article
|
